Skip to content

Comparison Of Two Ayurvedic Medicines Chinchapatra Ghana Vati And Vyoshadi Vati In Treating Allergic Rhinitis In Children Aged 5 To 16 Years

Clinical Comparative Study Of Vyoshadi Vati And Chinchapatra Ghan Vati In Management Of Kaphaj Pratishyay Of Age Group 5 To 16 Years - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105969
Enrollment
60
Registered
2026-03-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

None listed

Sponsors

Vd Prithviraj Shivraj Kadam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with Kaphaj Pratishaya symptoms for less than 7 days Children aged 5 to 16 years, irrespective of gender socioeconomic background or religion Patients/Parents or guardians provide informed consent for participation in the clinical trial Patients Who Are Physically And Mentally Fit To Undergo The Tteatment

Exclusion criteria

Exclusion criteria: Presence of muco purulent or blood-stained nasal discharge Patient with systemic illness Parents with febrile condition greater than 100degree Fahrenheit Children with nasal polyps or deviated nasal septum Cases where Pratishaya persists for more than 7 days Patients With All Congenital Malformations

Design outcomes

Primary

MeasureTime frame
Reduction in severity of symptoms of Kaphaja Pratishyaya using Total Nasal Symptom Score (TNSS) including rhinorrhea, sneezing, nasal obstruction and nasal itching.Timepoint: 7 Days

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Prithviraj Shivraj Kadam

Ashvin Rural Ayurved College And Hospital Manchi Hill Post Ashvi Bk Sangamner

guneameya10@gmail.com8600828132

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026